Global Respiratory Disease Testing Market to Grow at a CAGR of ~4% by 2030 | DelveInsight
DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...
The Financial Express3 日
Illumina to present updates on several key innovations in whole-genome sequencing at ASHG ...
On November 7, Illumina will showcase PIPseq V, a single-cell analysis solution currently on the market from Fluent BioSciences, an Illumina company.
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Invest in Natera, Inc. and GeneDx Holdings Corp. for potential growth in the booming precision medicine market. Click for ...
Microbiome Diagnostics Market to hit USD 429.2 million by 2032, says Global Market Insights ...
Microbiome diagnostics industry is projected to witness a CAGR of 13.4% during the period 2024-2032. This growth can be ...
Future Market Insights10 日
Short-Read Sequencing Market Expected to Reach USD 34,401.22 Million by 2033, Growing at a ...
Short-read Sequencing Market. The global short-read sequencing market is poised for substantial growth, with a projected market value of USD 6,322.03 million in 2023. According to ...
Zacks.com on MSN14 日
Illumina's Q3 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?
Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...
Asia One15 日
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
Designed to make next-generation sequencing accessible to more labs SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- Illumina, Inc.